Clinical risk factors for venous thromboembolus in users of the combined oral contraceptive pill
- 24 June 2002
- journal article
- Published by Wiley
- Vol. 53 (6) , 637-640
- https://doi.org/10.1046/j.1365-2125.2002.01606.x
Abstract
To estimate the risk of venous thromboembolism among women prescribed the oral contraceptive pill who have acute clinical conditions such as lower limb fractures, compared with women with idiopathic venous thromboembolism. A nested case-control analysis using the General Practice Research Database, January 1993 to December 1999 was carried out. The participants were women aged 15-39 years, prescribed third generation oral contraceptives (gestodene and desogestrel) or oral contraceptives containing levonorgestrel. The main outcome measures were odds ratios as a measure of the relative risk estimate for venous thromboembolism in women with clinical conditions that predispose to VTE. The adjusted relative risk estimate for venous thromboembolism among patients with the acute clinical conditions, compared with those without such illness, and adjusted for oral contraceptive use, was 17 (95% CI 6.5, 46). This paper documents the strong independent association between certain acute clinical conditions and venous thromboembolism in women prescribed oral contraceptives. Failure to accurately identify and exclude such patients from a study of the effect of oral contraceptives on the risk of venous thromboembolism would result in an underestimate of the risk of venous thromboembolism associated with oral contraceptives.Keywords
This publication has 12 references indexed in Scilit:
- Oral Contraceptives and the Risk of Venous ThrombosisNew England Journal of Medicine, 2001
- Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysisBMJ, 2000
- Principles of epidemiological research on adverse and beneficial drug effectsThe Lancet, 1998
- Pulmonary EmbolismNew England Journal of Medicine, 1998
- The General Practice Research Database. Scientific and Ethical Advisory GroupQJM: An International Journal of Medicine, 1998
- Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.1995
- Risk of idiopathic cardiovascular death and rionfatal venous thromboembolism in women using oral contraceptives with differing progestagen componentsThe Lancet, 1995
- Further validation of information recorded on a general practitioner based computerized data resource in the united kingdomPharmacoepidemiology and Drug Safety, 1992
- Validation of information recorded on general practitioner based computerised data resource in the United Kingdom.BMJ, 1991
- ORAL CONTRACEPTIVES AND VENOUS THROMBOEMBOLIC DISEASE, SURGICALLY CONFIRMED GALLBLADDER DISEASE, AND BREAST TUMOURS: Report from the Boston Collaborative Drug Surveillance ProgrammeThe Lancet, 1973